nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—CYP3A4—Estropipate—osteoporosis	0.103	0.181	CbGbCtD
Avanafil—CYP3A4—Calcitriol—osteoporosis	0.103	0.181	CbGbCtD
Avanafil—CYP3A4—Ergocalciferol—osteoporosis	0.0824	0.145	CbGbCtD
Avanafil—CYP3A4—Raloxifene—osteoporosis	0.0688	0.121	CbGbCtD
Avanafil—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0664	0.117	CbGbCtD
Avanafil—CYP3A4—Cholecalciferol—osteoporosis	0.0531	0.0934	CbGbCtD
Avanafil—CYP3A4—Conjugated Estrogens—osteoporosis	0.0488	0.0858	CbGbCtD
Avanafil—CYP3A4—Estradiol—osteoporosis	0.0428	0.0753	CbGbCtD
Avanafil—Malnutrition—Zoledronate—osteoporosis	0.000578	0.00134	CcSEcCtD
Avanafil—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000577	0.00134	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000577	0.00134	CcSEcCtD
Avanafil—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000576	0.00134	CcSEcCtD
Avanafil—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000575	0.00133	CcSEcCtD
Avanafil—Hypertension—Risedronate—osteoporosis	0.000575	0.00133	CcSEcCtD
Avanafil—Somnolence—Calcitriol—osteoporosis	0.000574	0.00133	CcSEcCtD
Avanafil—Infestation—Estradiol—osteoporosis	0.00057	0.00132	CcSEcCtD
Avanafil—Infestation NOS—Estradiol—osteoporosis	0.00057	0.00132	CcSEcCtD
Avanafil—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000569	0.00132	CcSEcCtD
Avanafil—Fatigue—Ibandronate—osteoporosis	0.000568	0.00132	CcSEcCtD
Avanafil—Arthralgia—Risedronate—osteoporosis	0.000567	0.00131	CcSEcCtD
Avanafil—Myalgia—Risedronate—osteoporosis	0.000567	0.00131	CcSEcCtD
Avanafil—Chest pain—Risedronate—osteoporosis	0.000567	0.00131	CcSEcCtD
Avanafil—Constipation—Ibandronate—osteoporosis	0.000564	0.00131	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000563	0.0013	CcSEcCtD
Avanafil—Pruritus—Etidronic acid—osteoporosis	0.000562	0.0013	CcSEcCtD
Avanafil—Mental disorder—Conjugated Estrogens—osteoporosis	0.00056	0.0013	CcSEcCtD
Avanafil—Back pain—Zoledronate—osteoporosis	0.000559	0.0013	CcSEcCtD
Avanafil—Malnutrition—Conjugated Estrogens—osteoporosis	0.000557	0.00129	CcSEcCtD
Avanafil—Muscle spasms—Zoledronate—osteoporosis	0.000556	0.00129	CcSEcCtD
Avanafil—Dry mouth—Risedronate—osteoporosis	0.000554	0.00128	CcSEcCtD
Avanafil—Urinary tract infection—Estradiol—osteoporosis	0.000554	0.00128	CcSEcCtD
Avanafil—Infection—Ethinyl Estradiol—osteoporosis	0.000554	0.00128	CcSEcCtD
Avanafil—Cough—Pamidronate—osteoporosis	0.000552	0.00128	CcSEcCtD
Avanafil—Constipation—Calcitriol—osteoporosis	0.000552	0.00128	CcSEcCtD
Avanafil—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000546	0.00127	CcSEcCtD
Avanafil—Hypertension—Pamidronate—osteoporosis	0.000546	0.00127	CcSEcCtD
Avanafil—Vision blurred—Zoledronate—osteoporosis	0.000545	0.00126	CcSEcCtD
Avanafil—Diarrhoea—Etidronic acid—osteoporosis	0.000544	0.00126	CcSEcCtD
Avanafil—Haematuria—Estradiol—osteoporosis	0.000543	0.00126	CcSEcCtD
Avanafil—Body temperature increased—Estropipate—osteoporosis	0.000543	0.00126	CcSEcCtD
Avanafil—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000541	0.00125	CcSEcCtD
Avanafil—Infection—Risedronate—osteoporosis	0.00054	0.00125	CcSEcCtD
Avanafil—Arthralgia—Pamidronate—osteoporosis	0.000539	0.00125	CcSEcCtD
Avanafil—Myalgia—Pamidronate—osteoporosis	0.000539	0.00125	CcSEcCtD
Avanafil—Back pain—Conjugated Estrogens—osteoporosis	0.000538	0.00125	CcSEcCtD
Avanafil—Epistaxis—Estradiol—osteoporosis	0.000538	0.00125	CcSEcCtD
Avanafil—Body temperature increased—Alendronate—osteoporosis	0.000535	0.00124	CcSEcCtD
Avanafil—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000535	0.00124	CcSEcCtD
Avanafil—Sinusitis—Estradiol—osteoporosis	0.000535	0.00124	CcSEcCtD
Avanafil—Nervous system disorder—Risedronate—osteoporosis	0.000533	0.00123	CcSEcCtD
Avanafil—Agitation—Zoledronate—osteoporosis	0.000531	0.00123	CcSEcCtD
Avanafil—Skin disorder—Risedronate—osteoporosis	0.000528	0.00122	CcSEcCtD
Avanafil—Body temperature increased—Raloxifene—osteoporosis	0.000526	0.00122	CcSEcCtD
Avanafil—Vision blurred—Conjugated Estrogens—osteoporosis	0.000524	0.00122	CcSEcCtD
Avanafil—Body temperature increased—Ibandronate—osteoporosis	0.000521	0.00121	CcSEcCtD
Avanafil—Vertigo—Zoledronate—osteoporosis	0.000519	0.0012	CcSEcCtD
Avanafil—Infection—Pamidronate—osteoporosis	0.000513	0.00119	CcSEcCtD
Avanafil—Palpitations—Zoledronate—osteoporosis	0.000511	0.00118	CcSEcCtD
Avanafil—Body temperature increased—Calcitriol—osteoporosis	0.00051	0.00118	CcSEcCtD
Avanafil—Nervous system disorder—Pamidronate—osteoporosis	0.000506	0.00117	CcSEcCtD
Avanafil—Urinary tract disorder—Estradiol—osteoporosis	0.000505	0.00117	CcSEcCtD
Avanafil—Vomiting—Etidronic acid—osteoporosis	0.000505	0.00117	CcSEcCtD
Avanafil—Cough—Zoledronate—osteoporosis	0.000504	0.00117	CcSEcCtD
Avanafil—Oedema peripheral—Estradiol—osteoporosis	0.000504	0.00117	CcSEcCtD
Avanafil—Tachycardia—Pamidronate—osteoporosis	0.000504	0.00117	CcSEcCtD
Avanafil—Connective tissue disorder—Estradiol—osteoporosis	0.000503	0.00117	CcSEcCtD
Avanafil—Urethral disorder—Estradiol—osteoporosis	0.000502	0.00116	CcSEcCtD
Avanafil—Rash—Etidronic acid—osteoporosis	0.000501	0.00116	CcSEcCtD
Avanafil—Dermatitis—Etidronic acid—osteoporosis	0.000501	0.00116	CcSEcCtD
Avanafil—Vertigo—Conjugated Estrogens—osteoporosis	0.0005	0.00116	CcSEcCtD
Avanafil—Hypertension—Zoledronate—osteoporosis	0.000499	0.00116	CcSEcCtD
Avanafil—Headache—Etidronic acid—osteoporosis	0.000498	0.00115	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000495	0.00115	CcSEcCtD
Avanafil—Asthenia—Estropipate—osteoporosis	0.000493	0.00114	CcSEcCtD
Avanafil—Myalgia—Zoledronate—osteoporosis	0.000492	0.00114	CcSEcCtD
Avanafil—Chest pain—Zoledronate—osteoporosis	0.000492	0.00114	CcSEcCtD
Avanafil—Arthralgia—Zoledronate—osteoporosis	0.000492	0.00114	CcSEcCtD
Avanafil—Palpitations—Conjugated Estrogens—osteoporosis	0.000492	0.00114	CcSEcCtD
Avanafil—Insomnia—Risedronate—osteoporosis	0.000491	0.00114	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000489	0.00113	CcSEcCtD
Avanafil—Pruritus—Estropipate—osteoporosis	0.000486	0.00113	CcSEcCtD
Avanafil—Asthenia—Alendronate—osteoporosis	0.000486	0.00113	CcSEcCtD
Avanafil—Cough—Conjugated Estrogens—osteoporosis	0.000486	0.00113	CcSEcCtD
Avanafil—Hypotension—Pamidronate—osteoporosis	0.000483	0.00112	CcSEcCtD
Avanafil—Dry mouth—Zoledronate—osteoporosis	0.000481	0.00112	CcSEcCtD
Avanafil—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000481	0.00112	CcSEcCtD
Avanafil—Fatigue—Ethinyl Estradiol—osteoporosis	0.00048	0.00111	CcSEcCtD
Avanafil—Pruritus—Alendronate—osteoporosis	0.000479	0.00111	CcSEcCtD
Avanafil—Dyspepsia—Risedronate—osteoporosis	0.000478	0.00111	CcSEcCtD
Avanafil—Eye disorder—Estradiol—osteoporosis	0.000478	0.00111	CcSEcCtD
Avanafil—Constipation—Ethinyl Estradiol—osteoporosis	0.000476	0.0011	CcSEcCtD
Avanafil—Flushing—Estradiol—osteoporosis	0.000475	0.0011	CcSEcCtD
Avanafil—Cardiac disorder—Estradiol—osteoporosis	0.000475	0.0011	CcSEcCtD
Avanafil—Arthralgia—Conjugated Estrogens—osteoporosis	0.000474	0.0011	CcSEcCtD
Avanafil—Myalgia—Conjugated Estrogens—osteoporosis	0.000474	0.0011	CcSEcCtD
Avanafil—Chest pain—Conjugated Estrogens—osteoporosis	0.000474	0.0011	CcSEcCtD
Avanafil—Asthenia—Ibandronate—osteoporosis	0.000473	0.0011	CcSEcCtD
Avanafil—Nausea—Etidronic acid—osteoporosis	0.000472	0.00109	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000471	0.00109	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00047	0.00109	CcSEcCtD
Avanafil—Diarrhoea—Estropipate—osteoporosis	0.00047	0.00109	CcSEcCtD
Avanafil—Gastrointestinal disorder—Risedronate—osteoporosis	0.000469	0.00109	CcSEcCtD
Avanafil—Infection—Zoledronate—osteoporosis	0.000469	0.00109	CcSEcCtD
Avanafil—Fatigue—Risedronate—osteoporosis	0.000468	0.00109	CcSEcCtD
Avanafil—Insomnia—Pamidronate—osteoporosis	0.000467	0.00108	CcSEcCtD
Avanafil—Pruritus—Ibandronate—osteoporosis	0.000466	0.00108	CcSEcCtD
Avanafil—Constipation—Risedronate—osteoporosis	0.000465	0.00108	CcSEcCtD
Avanafil—Angiopathy—Estradiol—osteoporosis	0.000464	0.00108	CcSEcCtD
Avanafil—Diarrhoea—Alendronate—osteoporosis	0.000463	0.00107	CcSEcCtD
Avanafil—Asthenia—Calcitriol—osteoporosis	0.000463	0.00107	CcSEcCtD
Avanafil—Nervous system disorder—Zoledronate—osteoporosis	0.000463	0.00107	CcSEcCtD
Avanafil—Immune system disorder—Estradiol—osteoporosis	0.000462	0.00107	CcSEcCtD
Avanafil—Mediastinal disorder—Estradiol—osteoporosis	0.000461	0.00107	CcSEcCtD
Avanafil—Tachycardia—Zoledronate—osteoporosis	0.00046	0.00107	CcSEcCtD
Avanafil—Somnolence—Pamidronate—osteoporosis	0.000459	0.00106	CcSEcCtD
Avanafil—Skin disorder—Zoledronate—osteoporosis	0.000458	0.00106	CcSEcCtD
Avanafil—Pruritus—Calcitriol—osteoporosis	0.000457	0.00106	CcSEcCtD
Avanafil—Diarrhoea—Raloxifene—osteoporosis	0.000456	0.00106	CcSEcCtD
Avanafil—Dyspepsia—Pamidronate—osteoporosis	0.000455	0.00105	CcSEcCtD
Avanafil—Dizziness—Estropipate—osteoporosis	0.000455	0.00105	CcSEcCtD
Avanafil—Infection—Conjugated Estrogens—osteoporosis	0.000451	0.00105	CcSEcCtD
Avanafil—Diarrhoea—Ibandronate—osteoporosis	0.000451	0.00105	CcSEcCtD
Avanafil—Mental disorder—Estradiol—osteoporosis	0.000448	0.00104	CcSEcCtD
Avanafil—Dizziness—Alendronate—osteoporosis	0.000448	0.00104	CcSEcCtD
Avanafil—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000446	0.00103	CcSEcCtD
Avanafil—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000445	0.00103	CcSEcCtD
Avanafil—Malnutrition—Estradiol—osteoporosis	0.000445	0.00103	CcSEcCtD
Avanafil—Fatigue—Pamidronate—osteoporosis	0.000445	0.00103	CcSEcCtD
Avanafil—Tachycardia—Conjugated Estrogens—osteoporosis	0.000443	0.00103	CcSEcCtD
Avanafil—Constipation—Pamidronate—osteoporosis	0.000442	0.00102	CcSEcCtD
Avanafil—Diarrhoea—Calcitriol—osteoporosis	0.000441	0.00102	CcSEcCtD
Avanafil—Skin disorder—Conjugated Estrogens—osteoporosis	0.000441	0.00102	CcSEcCtD
Avanafil—Hypotension—Zoledronate—osteoporosis	0.000441	0.00102	CcSEcCtD
Avanafil—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00044	0.00102	CcSEcCtD
Avanafil—Dizziness—Raloxifene—osteoporosis	0.00044	0.00102	CcSEcCtD
Avanafil—Vomiting—Estropipate—osteoporosis	0.000437	0.00101	CcSEcCtD
Avanafil—Dizziness—Ibandronate—osteoporosis	0.000436	0.00101	CcSEcCtD
Avanafil—Rash—Estropipate—osteoporosis	0.000433	0.001	CcSEcCtD
Avanafil—Dermatitis—Estropipate—osteoporosis	0.000433	0.001	CcSEcCtD
Avanafil—Back pain—Estradiol—osteoporosis	0.000431	0.000999	CcSEcCtD
Avanafil—Headache—Estropipate—osteoporosis	0.000431	0.000998	CcSEcCtD
Avanafil—Vomiting—Alendronate—osteoporosis	0.00043	0.000998	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00043	0.000996	CcSEcCtD
Avanafil—Body temperature increased—Risedronate—osteoporosis	0.000429	0.000995	CcSEcCtD
Avanafil—Muscle spasms—Estradiol—osteoporosis	0.000428	0.000993	CcSEcCtD
Avanafil—Rash—Alendronate—osteoporosis	0.000427	0.00099	CcSEcCtD
Avanafil—Insomnia—Zoledronate—osteoporosis	0.000427	0.000989	CcSEcCtD
Avanafil—Dermatitis—Alendronate—osteoporosis	0.000426	0.000989	CcSEcCtD
Avanafil—Hypotension—Conjugated Estrogens—osteoporosis	0.000424	0.000984	CcSEcCtD
Avanafil—Headache—Alendronate—osteoporosis	0.000424	0.000983	CcSEcCtD
Avanafil—Vomiting—Raloxifene—osteoporosis	0.000423	0.000981	CcSEcCtD
Avanafil—Rash—Raloxifene—osteoporosis	0.00042	0.000973	CcSEcCtD
Avanafil—Dermatitis—Raloxifene—osteoporosis	0.000419	0.000972	CcSEcCtD
Avanafil—Somnolence—Zoledronate—osteoporosis	0.000419	0.000972	CcSEcCtD
Avanafil—Vomiting—Ibandronate—osteoporosis	0.000419	0.000972	CcSEcCtD
Avanafil—Headache—Raloxifene—osteoporosis	0.000417	0.000967	CcSEcCtD
Avanafil—Rash—Ibandronate—osteoporosis	0.000416	0.000963	CcSEcCtD
Avanafil—Dermatitis—Ibandronate—osteoporosis	0.000415	0.000963	CcSEcCtD
Avanafil—Dyspepsia—Zoledronate—osteoporosis	0.000415	0.000963	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000414	0.000959	CcSEcCtD
Avanafil—Headache—Ibandronate—osteoporosis	0.000413	0.000957	CcSEcCtD
Avanafil—Insomnia—Conjugated Estrogens—osteoporosis	0.000411	0.000952	CcSEcCtD
Avanafil—Vomiting—Calcitriol—osteoporosis	0.00041	0.000951	CcSEcCtD
Avanafil—Agitation—Estradiol—osteoporosis	0.000409	0.000949	CcSEcCtD
Avanafil—Nausea—Estropipate—osteoporosis	0.000408	0.000946	CcSEcCtD
Avanafil—Body temperature increased—Pamidronate—osteoporosis	0.000408	0.000946	CcSEcCtD
Avanafil—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000407	0.000944	CcSEcCtD
Avanafil—Rash—Calcitriol—osteoporosis	0.000407	0.000943	CcSEcCtD
Avanafil—Fatigue—Zoledronate—osteoporosis	0.000407	0.000943	CcSEcCtD
Avanafil—Dermatitis—Calcitriol—osteoporosis	0.000406	0.000942	CcSEcCtD
Avanafil—Headache—Calcitriol—osteoporosis	0.000404	0.000937	CcSEcCtD
Avanafil—Somnolence—Conjugated Estrogens—osteoporosis	0.000404	0.000936	CcSEcCtD
Avanafil—Constipation—Zoledronate—osteoporosis	0.000403	0.000935	CcSEcCtD
Avanafil—Nausea—Alendronate—osteoporosis	0.000402	0.000932	CcSEcCtD
Avanafil—Vertigo—Estradiol—osteoporosis	0.0004	0.000928	CcSEcCtD
Avanafil—Dyspepsia—Conjugated Estrogens—osteoporosis	0.0004	0.000927	CcSEcCtD
Avanafil—Asthenia—Ethinyl Estradiol—osteoporosis	0.0004	0.000927	CcSEcCtD
Avanafil—Nausea—Raloxifene—osteoporosis	0.000396	0.000917	CcSEcCtD
Avanafil—Pruritus—Ethinyl Estradiol—osteoporosis	0.000394	0.000914	CcSEcCtD
Avanafil—Palpitations—Estradiol—osteoporosis	0.000394	0.000912	CcSEcCtD
Avanafil—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000392	0.000909	CcSEcCtD
Avanafil—Fatigue—Conjugated Estrogens—osteoporosis	0.000392	0.000908	CcSEcCtD
Avanafil—Nausea—Ibandronate—osteoporosis	0.000392	0.000908	CcSEcCtD
Avanafil—Asthenia—Risedronate—osteoporosis	0.00039	0.000903	CcSEcCtD
Avanafil—Cough—Estradiol—osteoporosis	0.000389	0.000901	CcSEcCtD
Avanafil—Constipation—Conjugated Estrogens—osteoporosis	0.000388	0.0009	CcSEcCtD
Avanafil—Hypertension—Estradiol—osteoporosis	0.000385	0.000891	CcSEcCtD
Avanafil—Pruritus—Risedronate—osteoporosis	0.000384	0.000891	CcSEcCtD
Avanafil—Nausea—Calcitriol—osteoporosis	0.000383	0.000888	CcSEcCtD
Avanafil—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000381	0.000884	CcSEcCtD
Avanafil—Myalgia—Estradiol—osteoporosis	0.000379	0.000879	CcSEcCtD
Avanafil—Chest pain—Estradiol—osteoporosis	0.000379	0.000879	CcSEcCtD
Avanafil—Arthralgia—Estradiol—osteoporosis	0.000379	0.000879	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000377	0.000873	CcSEcCtD
Avanafil—Body temperature increased—Zoledronate—osteoporosis	0.000373	0.000864	CcSEcCtD
Avanafil—Diarrhoea—Risedronate—osteoporosis	0.000372	0.000862	CcSEcCtD
Avanafil—Dry mouth—Estradiol—osteoporosis	0.000371	0.00086	CcSEcCtD
Avanafil—Asthenia—Pamidronate—osteoporosis	0.000371	0.000859	CcSEcCtD
Avanafil—Dizziness—Ethinyl Estradiol—osteoporosis	0.000368	0.000854	CcSEcCtD
Avanafil—Pruritus—Pamidronate—osteoporosis	0.000365	0.000847	CcSEcCtD
Avanafil—Infection—Estradiol—osteoporosis	0.000361	0.000837	CcSEcCtD
Avanafil—Dizziness—Risedronate—osteoporosis	0.000359	0.000833	CcSEcCtD
Avanafil—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000359	0.000832	CcSEcCtD
Avanafil—Nervous system disorder—Estradiol—osteoporosis	0.000356	0.000826	CcSEcCtD
Avanafil—Tachycardia—Estradiol—osteoporosis	0.000355	0.000822	CcSEcCtD
Avanafil—Vomiting—Ethinyl Estradiol—osteoporosis	0.000354	0.000821	CcSEcCtD
Avanafil—Diarrhoea—Pamidronate—osteoporosis	0.000353	0.000819	CcSEcCtD
Avanafil—Skin disorder—Estradiol—osteoporosis	0.000353	0.000818	CcSEcCtD
Avanafil—Rash—Ethinyl Estradiol—osteoporosis	0.000351	0.000814	CcSEcCtD
Avanafil—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000351	0.000814	CcSEcCtD
Avanafil—Headache—Ethinyl Estradiol—osteoporosis	0.000349	0.000809	CcSEcCtD
Avanafil—Vomiting—Risedronate—osteoporosis	0.000345	0.000801	CcSEcCtD
Avanafil—Rash—Risedronate—osteoporosis	0.000343	0.000794	CcSEcCtD
Avanafil—Dermatitis—Risedronate—osteoporosis	0.000342	0.000793	CcSEcCtD
Avanafil—Dizziness—Pamidronate—osteoporosis	0.000341	0.000792	CcSEcCtD
Avanafil—Headache—Risedronate—osteoporosis	0.00034	0.000789	CcSEcCtD
Avanafil—Asthenia—Zoledronate—osteoporosis	0.000338	0.000785	CcSEcCtD
Avanafil—Pruritus—Zoledronate—osteoporosis	0.000334	0.000774	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000331	0.000768	CcSEcCtD
Avanafil—Nausea—Ethinyl Estradiol—osteoporosis	0.000331	0.000767	CcSEcCtD
Avanafil—Insomnia—Estradiol—osteoporosis	0.000329	0.000762	CcSEcCtD
Avanafil—Vomiting—Pamidronate—osteoporosis	0.000328	0.000761	CcSEcCtD
Avanafil—Asthenia—Conjugated Estrogens—osteoporosis	0.000326	0.000755	CcSEcCtD
Avanafil—Rash—Pamidronate—osteoporosis	0.000326	0.000755	CcSEcCtD
Avanafil—Dermatitis—Pamidronate—osteoporosis	0.000325	0.000754	CcSEcCtD
Avanafil—Headache—Pamidronate—osteoporosis	0.000324	0.00075	CcSEcCtD
Avanafil—Somnolence—Estradiol—osteoporosis	0.000323	0.000749	CcSEcCtD
Avanafil—Diarrhoea—Zoledronate—osteoporosis	0.000323	0.000748	CcSEcCtD
Avanafil—Nausea—Risedronate—osteoporosis	0.000323	0.000748	CcSEcCtD
Avanafil—Pruritus—Conjugated Estrogens—osteoporosis	0.000321	0.000745	CcSEcCtD
Avanafil—Dyspepsia—Estradiol—osteoporosis	0.00032	0.000742	CcSEcCtD
Avanafil—Gastrointestinal disorder—Estradiol—osteoporosis	0.000314	0.000727	CcSEcCtD
Avanafil—Fatigue—Estradiol—osteoporosis	0.000313	0.000726	CcSEcCtD
Avanafil—Dizziness—Zoledronate—osteoporosis	0.000312	0.000723	CcSEcCtD
Avanafil—Constipation—Estradiol—osteoporosis	0.000311	0.000721	CcSEcCtD
Avanafil—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000311	0.00072	CcSEcCtD
Avanafil—Nausea—Pamidronate—osteoporosis	0.000307	0.000711	CcSEcCtD
Avanafil—Dizziness—Conjugated Estrogens—osteoporosis	0.0003	0.000696	CcSEcCtD
Avanafil—Vomiting—Zoledronate—osteoporosis	0.0003	0.000695	CcSEcCtD
Avanafil—Rash—Zoledronate—osteoporosis	0.000297	0.000689	CcSEcCtD
Avanafil—Dermatitis—Zoledronate—osteoporosis	0.000297	0.000689	CcSEcCtD
Avanafil—Headache—Zoledronate—osteoporosis	0.000296	0.000685	CcSEcCtD
Avanafil—Vomiting—Conjugated Estrogens—osteoporosis	0.000289	0.000669	CcSEcCtD
Avanafil—Body temperature increased—Estradiol—osteoporosis	0.000287	0.000666	CcSEcCtD
Avanafil—Rash—Conjugated Estrogens—osteoporosis	0.000286	0.000664	CcSEcCtD
Avanafil—Dermatitis—Conjugated Estrogens—osteoporosis	0.000286	0.000663	CcSEcCtD
Avanafil—Headache—Conjugated Estrogens—osteoporosis	0.000285	0.00066	CcSEcCtD
Avanafil—Nausea—Zoledronate—osteoporosis	0.00028	0.000649	CcSEcCtD
Avanafil—Nausea—Conjugated Estrogens—osteoporosis	0.00027	0.000625	CcSEcCtD
Avanafil—Asthenia—Estradiol—osteoporosis	0.000261	0.000605	CcSEcCtD
Avanafil—Pruritus—Estradiol—osteoporosis	0.000257	0.000596	CcSEcCtD
Avanafil—Diarrhoea—Estradiol—osteoporosis	0.000249	0.000577	CcSEcCtD
Avanafil—Dizziness—Estradiol—osteoporosis	0.00024	0.000557	CcSEcCtD
Avanafil—Vomiting—Estradiol—osteoporosis	0.000231	0.000536	CcSEcCtD
Avanafil—Rash—Estradiol—osteoporosis	0.000229	0.000531	CcSEcCtD
Avanafil—Dermatitis—Estradiol—osteoporosis	0.000229	0.000531	CcSEcCtD
Avanafil—Headache—Estradiol—osteoporosis	0.000228	0.000528	CcSEcCtD
Avanafil—Nausea—Estradiol—osteoporosis	0.000216	0.000501	CcSEcCtD
